Continuous Tableting Lines

At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.

Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:

 

  • by collecting more information during R&D phase, in a short time with less product
  • by excluding risky, time- and product consuming scale-up exercises
  • by introducing online measurement and closed loop control targeting real-time release (6 sigma production)
  • by incorporating flexible batch size (JIT production), reducing inventory
  • by reducing the energy cost per tablet, reducing environmental impact. 

GEA Insights

A bowl of pasta with cultivated meat

GEA brings alternative protein expertise to U.S.

A new GEA technology center for developing alternatives to meat, dairy, seafood and eggs in Wisconsin, will help accelerate novel food production in the U.S. market

Future-proofing the cold chain with sustainable refrigeration

The importance of quality cold chain management cannot be underestimated. Ensuring that perishable foodstuffs are safe and of high quality at the point of consumption is a tremendous responsibility for those operating cold chain...

GEA supports clean water projects in Tanzania

Access to safe water and sanitation is still a challenge in a lot of countries. Illness from dirty drinking water and daily treks to fetch it, mean many children cannot attend school. Thanks to a collaboration with Hamburg-based...

Receive news from GEA

Stay in touch with GEA innovations and stories by signing up for news from GEA.

Contact us

We are here to help! With just a few details we will be able to respond to your inquiry.